Flmodafinil CAS:90280-13-0
Product Quick Detail
- Place Of Origin
- China
- Minimum Order
- 5
- Packaging
- 1-2 kg / aluminum foil bag, 25kg/ drum, as required
- Delivery
- within 3 days when get the payment
Specifications
1. Specification:
CRL-40,940
CAS: 90280-13-0
Appearance: White crystalline powder
Assay: 99%
2. Introduction:
CRL-40,940 is a selective dopaminergic reuptake inhibitor, and is the bisfluoro analog of the wakefulness-promoting agent and has been sold online as a designer drug.The experts claim that it is more effective than adrafinil in their indications with fewer side effects.Phase I clinical trials have been underway since December 2015.
3. Application:
Used in medicine, health products, food, beverage, cosmetics, biological and chemical reagents and other industries.
4. Health Benefits /Uses:
CRL-40,940 (Fluoromodafinil) is an eugeroic related to and of higher potency. Main active metabolite of Fladrafinil.
Packaging Details:
25kgs packaging Fiber drum outside and plastic bag inside 1-25kgs packaging aluminium bag outside and double plastic bag inside
Delivery Detail: within 3 days when get the payment
Shipping :
We have Professional shipping agent, based on customers ' demand for transport
By express :FEDEX,DHL,EMS ,UPS,TNT ect.
By SEA and By AIR
- Country: China (Mainland)
- Business Type: Manufacturer,Distributor/Wholesaler,Agent,Exporter,Trading CompanySeller,Other,贸易公司
- Market:Africa,North America,South America,Western Europe,Eastern Europe,Eastern Asia,Southeast Asia,Middle East,Africa,Oceania,Worldwid
- Founded Year:2009
- Address:Rm. 77, Cimic Tower, 1090 Cengtury Blvd, Pudong, Shanghai, China
- Contact:HAN Bess
Other products from Shanghai Oster Biotechnology Co.,Ltd
Relate products of Flmodafinil CAS:90280-13-0
1. Specification: CRL-40,940 CAS: 90280-13-0 Appearance: White crystalline powder Assay: 99% 2. Introduction: CRL-40,940 is a selective dopaminergic reuptake inhibitor, and is the bisfluoro analog of the wakefulness-promoting agent and has been sold online as a designer ...
